236 related articles for article (PubMed ID: 17844897)
1. Antiemetic agents.
Wilkes G
Oncology (Williston Park); 2007 Jul; 21(8 Suppl):48. PubMed ID: 17844897
[No Abstract] [Full Text] [Related]
2. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
[TBL] [Abstract][Full Text] [Related]
3. [Achieving optimal antiemetic management].
Krankenpfl J; 2005; 43(7-10):226-7. PubMed ID: 16515295
[No Abstract] [Full Text] [Related]
4. [Medical treatment of chemotherapy-induced nausea and vomiting].
Herrstedt J
Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
[TBL] [Abstract][Full Text] [Related]
5. Palonosetron compared with ondansetron in pediatric cancer patients: multicycle analysis of a randomized Phase III study.
Kovács G; Wachtel A; Basharova E; Spinelli T; Nicolas P; Kabickova E
Future Oncol; 2017 Aug; 13(19):1685-1698. PubMed ID: 28569078
[TBL] [Abstract][Full Text] [Related]
6. Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria.
Raftopoulos H; Boccia R; Cooper W; O'Boyle E; Gralla RJ
Future Oncol; 2015 Sep; 11(18):2541-51. PubMed ID: 26289588
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers].
Alon E; Biro P
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 May; 31(4):200-4. PubMed ID: 8704077
[TBL] [Abstract][Full Text] [Related]
8. Comparison of healthcare resource use between patients receiving ondansetron or palonosetron as prophylaxis for chemotherapy-induced nausea and vomiting.
Yeh YC; McDonnell A; Klinger E; Fowler B; Matta L; Voit D; Reddy P
J Oncol Pharm Pract; 2011 Sep; 17(3):179-85. PubMed ID: 20452991
[TBL] [Abstract][Full Text] [Related]
9. A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapy.
Merrouche Y; Catimel G; Rebattu P; Dumortier A; Guastalla JP; O'Grady P; Clavel M
Ann Oncol; 1994 Jul; 5(6):549-51. PubMed ID: 7918128
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancer.
Kaushal J; Gupta MC; Kaushal V; Bhutani G; Dhankar R; Atri R; Verma S
Singapore Med J; 2010 Nov; 51(11):871-5. PubMed ID: 21140114
[TBL] [Abstract][Full Text] [Related]
11. Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report.
Demir HA; Batu ED; Yalçın B; Civelek E; Saçkesen C; Büyükpamukçu M
J Pediatr Hematol Oncol; 2010 Nov; 32(8):e341-2. PubMed ID: 20921907
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
[TBL] [Abstract][Full Text] [Related]
13. Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study.
Tan M; Xu R; Seth R
Curr Med Res Opin; 2004 Jun; 20(6):879-82. PubMed ID: 15200746
[TBL] [Abstract][Full Text] [Related]
14. Writers challenge points made in article about antiemetic therapy.
Carroll-Johnson RM
Oncol Nurs Forum; 2003; 30(6):892; author reply 892. PubMed ID: 14608986
[No Abstract] [Full Text] [Related]
15. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
16. A granisetron patch (sancuso).
Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):103-4; quiz p 2 following 104. PubMed ID: 19078867
[No Abstract] [Full Text] [Related]
17. Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
Tan M
Expert Opin Pharmacother; 2003 Sep; 4(9):1563-71. PubMed ID: 12943486
[TBL] [Abstract][Full Text] [Related]
18. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB
Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
[TBL] [Abstract][Full Text] [Related]
19. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal complication of cancer chemotherapy].
Hamaguchi T
Nihon Rinsho; 2007 Oct; 65 Suppl 8():281-6. PubMed ID: 18074549
[No Abstract] [Full Text] [Related]
[Next] [New Search]
